We are pleased to announce an MoU with JSS Medical College and Academy of Higher Education and Research, Mysuru to work together in the areas of hemoglobinopathies and rare diseases. The aim is to work on collaborative projects to develop affordable and efficient diagnostics, therapeutics, and treatment options.
Related Posts
TIGS scientists present their work at International conference on Genetics and Genomics in Health and Diseases
Scientists from TIGS presented their work at the recently concluded 8th Annual... read more
Monkeypox Scare Gets Real In India: Are We Prepared? | Left, Right & Centre Interview with NDTV
All about Monkeypox, What, Why and How? Watch Dr. Rakesh Mishra, Director TIGS,... read more
On XE Varaiant of Omicron
COVID mutant 'XE': TIGS Director Rakesh Mishra urges citizens not to panic,... read more
TIGS at Bengaluru Tech Summit 2022
Dr. Farah Ishtiaq, Principal Scientist, TIGS was a panelist on 'OneHealth and... read more
Antimicrobial Resistance has become a ‘silent pandemic’
Speaking to The Hindu, Dr. Rakesh Mishra, Director, TIGS highlights the threat... read more
REDRESS 2024 – Advancing rare genetic disorder research together!
✨ We are thrilled to announce the successful completion of the 3rd... read more
Mosquito surveillance must include non-residential urban environments
Dr. Farah Ishtiaq and teams' recent work on outdoor mosquito surveillance highlights... read more
OneHealth national agenda meeting
A meeting at Indian Institute for Science (IISc), involving various academic, research... read more
Why environmental surveillance for avian influenza is vital
Wastewater-based epidemiology or pathogen surveillance has become an integral component of environmental surveillance... read more